(Q84763001)
Statements
Tocilizumab improved both clinical and laboratory manifestations except for interleukin-18 in a case of multiple drug-resistant adult-onset Still's disease (English)
Yoshihiro Yoshida
Mayuko Sakamoto
Kazuhiro Yokota
Kojiro Sato
Toshihide Mimura